跳至主要内容
临床试验/NCT00580749
NCT00580749终止不适用

Feeding and Pancreatic Rest in Acute Pancreatitis

University of Pittsburgh8 个研究点 分布在 1 个国家目标入组 23 人开始时间: 2010年1月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
23
试验地点
8
主要终点
Feeding success as determined by the quantity of nutrition delivered and the number of interruptions due to intolerance and how the two forms of feeding influence disease outcome as measured by duration of ICU and hospital stay.

研究概览

简要总结

We will compare the two types of enteral (intestinal) nutrition in regard to patients with severe acute pancreatitis in our institution and also in 8 others in the United States.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients over the age of 18yr
  • The typical history of abdominal pain for over 24h with raised (>3-fold) serum pancreatic enzymes on admission
  • Severe pancreatitis, as defined by: the Atlanta classification of severe disease (60), but with important modifications to sharpen the definition of severity, to include one or more of the following:
  • The presence of organ failure (MOF) resistant to early aggressive IV fluid resuscitation as defined by a Marshall score of ≥2 in any one organ (for calculation, see Appendix (61)), excluding the liver component as the abnormality may be due to gall stones rather than the systemic inflammatory response (17)
  • Pancreatic necrosis >30% on CT scan or a modified CT severity index (CTSI: see Appendix (62)) of ≥8
  • APACHE score ≥ 8 (for calculation, see Appendix (63))
  • Ranson's criteria ≥3 (for calculation, see Appendix (64))

排除标准

  • Inability to absorb enteral nutrients resulting in chronic intestinal failure and need for IV feeding, such as short bowel, malabsorption disorders such as celiac or intestinal proliferative disorders, chronic obstruction and pseudo-obstruction.
  • Time elapse since commencement of acute pancreatitis symptoms >10 days. In order to take advantage of the 'window of opportunity' to prevent the progression of 'transient' MOF to 'permanent' MOF, patients should be started on enteral feeding as soon as possible. However, in practice many patients present initially with mild disease which progresses to severe necrosis at the end of the first week, and these patients need nutritional support for long periods of time. Consequently, this is an important group to include in this investigation. Post hoc analysis will be performed to see whether they behave differently to patients fed earlier in their disease
  • Any form of artificial feeding since commencement of acute pancreatitis symptoms
  • Patients with chronic pancreatitis and pancreatic insufficiency requiring pancreatic enzyme supplements, based on clinical history and specific investigations such as by ERCP, MRP, or CT scanning.
  • Pre-existing chronic renal insufficiency requiring hemodialysis or peritoneal dialysis, as this will make assessment of severity difficult
  • Pre-existing end-stage liver disease with ascites, coagulopathy and encephalopathy, supported by biopsy, and/or radiological imaging and endoscopy (portal hypertension, varices and gastropathy), as this will make assessment of severity difficult
  • Chronic immunodeficiency states such as AIDS defined by CD-4 count < 50, and immunoglobulin deficiencies as it may independently affect feeding tolerance and infection risk
  • Pancreatic cancer proven by biopsy, and any other form of cancer with life-expectancy <6 months.
  • Current somatostatin or corticosteroid therapy as these drugs will impair intestinal, metabolic, and immune function, and therefore affect absorption and infection risk.
  • Contraindication to using the nose for enteral tube insertion
  • Severe traumatic brain injury with ICP>20mmHg despite treatment
  • Previous completion or withdrawal from this study

结局指标

主要结局

Feeding success as determined by the quantity of nutrition delivered and the number of interruptions due to intolerance and how the two forms of feeding influence disease outcome as measured by duration of ICU and hospital stay.

时间窗: Approx. one week

次要结局

  • Feeding tolerance (nitrogen balance, stool volume, incidence of nausea, incidence of nausea and vomiting) will demonstrate better tolerance for subjects undergoing DJ feeding than those undergoing NG feeding.(Approx. one week)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

David Whitcomb

MD

University of Pittsburgh

研究点 (8)

Loading locations...

相似试验